A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC)
Clinical trial NCT02029157 · COMPLETED
Trial details
- NCT number
- NCT02029157
- Sponsor
- Kyowa Kirin Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2017-08-01
- Enrollment
- 386
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.